Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Neurological diseases and metabolism, and Botulinum Toxin and Related Neurological Disorders.
Reduced striatal dopamine transmission as a transdiagnostic substrate of psychomotor retardation.
A Pioneering 1915 Film on Movement Disorders in Spain: Parkinsonism, Huntington's Disease, and Paradoxical Kinesia.
Beyond Pathology: α-Synuclein Homeostasis and Three Principles to Guide Research.
Refutation of the αSyn-SAA-Based Staging for Parkinson's Progression (Neuronal α-Synuclein Disease-Integrated Staging System [NSD-ISS]).
"The Machine Will See You Now": A Clinician's Perspective on Artificial "Intelligence" In Clinical Care.
The Dopamine Dancer: The Value of Holistic Autotherapy in Parkinson's Disease.
Licensed Subcutaneous Infusion Therapies in Advanced Parkinson's Disease: An Indirect Treatment Comparison and Cost-Minimisation Analysis.
Two London Memorials to "James Parkinson [1755-1824], Esq. Surgeon, Late of Hoxton-Square".
Мiryachit: A Culture-Specific Startle Syndrome in the Saami People.
Voluntary and involuntary motor behaviours in the varieties of religious experience.
Handwriting patterns in Isolated Rapid Eye Movement Sleep Behaviour Disorder
The Sacks epistles: how fame reduces the punch of literary letters
Medical, surgical, and physical treatments for Parkinson's disease
The impact of psychiatric comorbidity on Parkinson's disease outcomes: a systematic review and meta-analysis
Are we entering the 'Tau-lemaic' era of Parkinson's disease?
Neuroimaging and plasma evidence of early white matter loss in Parkinson's disease with poor outcomes.
Small Particles, Big Potential: Polymeric Nanoparticles for Drug Delivery in Parkinson's Disease.
Encephalitis lethargica: clinical features and aetiology.
Copper rings, blue moons and sunflower cataracts.
Corticobasal degeneration: An update
The East London Parkinson’s Disease Project – A case-control study in a diverse population
Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials.
Intermittent Apomorphine Use for off Period Rescue in Parkinson's Disease: A Pragmatic Review of over Three Decades of Clinical Experience.
Neuroimaging and plasma marker evidence for white matter macrostructure loss in Parkinson’s disease
Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's disease.
The prevalence of impulsive compulsive behaviors in patients treated with apomorphine infusion: a retrospective analysis.